Last reviewed · How we verify
placebo in sublingual applicator
A placebo in sublingual applicator form produces therapeutic effects through the placebo response mechanism, wherein patient expectation and psychological factors influence symptom perception and outcomes.
At a glance
| Generic name | placebo in sublingual applicator |
|---|---|
| Sponsor | Medical University of Lodz |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebos work through multiple psychological and neurobiological pathways including expectation, conditioning, and activation of endogenous pain-relief systems. In a sublingual applicator format, the placebo is designed to be absorbed or dissolved under the tongue, potentially enhancing the ritualistic and sensory components of the placebo response. The therapeutic effect is not due to pharmacological activity of the formulation itself, but rather the patient's belief and the clinical context in which it is administered.
Approved indications
Common side effects
Key clinical trials
- The Use of Photobiomodulation in the Treatment of Oral Complaints of Long COVID-19.A Randomized Controlled Trial. (PHASE2)
- Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy (PHASE3)
- Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain (PHASE3)
- Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis (PHASE3)
- Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis (PHASE3)
- Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy (PHASE3)
- Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy (PHASE3)
- Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- placebo in sublingual applicator CI brief — competitive landscape report
- placebo in sublingual applicator updates RSS · CI watch RSS
- Medical University of Lodz portfolio CI